Alexion
121 Seaport Blvd Boston
Boston
MA
02210
United States
Tel: 475-230-2596
Website: http://www.alexion.com/
735 articles about Alexion
-
Alexion Pharmaceuticals Inc. Release: Substantial Disease Burden of PNH Demonstrated in Data from International and Asian Patient Registries Presented at European Hematology Association
6/14/2010
-
Alexion Pharmaceuticals Inc. to Present at Investor Conferences
6/8/2010
-
Alexion Pharmaceuticals Inc. to Present at Investor Conferences
6/2/2010
-
Alexion Pharmaceuticals Inc. Moves Up Japanese Launch of Soliris
6/2/2010
-
Alexion Pharmaceuticals Inc. the Appointment of Ann M. Veneman to Its Board of Directors
6/1/2010
-
Alexion Pharmaceuticals Inc. Research to be Presented at the American Transplant Congress Examines the Role of Terminal Complement Inhibition in the Treatment of Kidney Transplantation Patients
4/30/2010
-
Alexion Pharmaceuticals Inc. Reports First Quarter 2010 Results
4/22/2010
-
Alexion Pharmaceuticals Inc. Completes Enrollment in All Four Clinical Trials of Soliris(R) (eculizumab) in Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
4/20/2010
-
Alexion Pharmaceuticals Inc.'s Soliris(R) (Eculizumab) Receives Marketing Approval in Japan for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
4/16/2010
-
Alexion Pharmaceuticals Inc. to Report First Quarter Results on Thursday, April 22, 2010
4/8/2010
-
Alexion Pharmaceuticals Inc. to Present at the Cowen and Company 30th Annual Health Care Conference
3/2/2010
-
Alexion Pharmaceuticals Inc. Joins NORD, EURORDIS and Other Patient Advocacy Groups in Supporting the Goals of Rare Disease Day 2010
2/26/2010
-
Alexion Pharmaceuticals Inc. Reports Fourth Quarter and Full Year 2009 Results
2/11/2010
-
Alexion Pharmaceuticals Inc. to Report Fourth Quarter and Full Year 2009 Results on February 11, 2010
1/28/2010
-
Alexion Pharmaceuticals Inc. to Present at the 28th Annual JP Morgan Healthcare Conference
1/6/2010
-
Alexion Pharmaceuticals Inc.'s Soliris(R) Reversed Thrombocytopenia in Patients with Both PNH and Pre-Existing Thrombocytopenia in Study Presented at American Society of Hematology Annual Meeting
12/7/2009
-
Alexion Pharmaceuticals Inc.'s Soliris(R) Reduced Hemolysis, Decreased Transfusion Requirements and Improved Fatigue in Patients with PNH and Bone Marrow Insufficiency Disorders
12/7/2009
-
Alexion Pharmaceuticals Inc. Manufacturing Unit Gets Positive CHMP Opinion
12/2/2009
-
Alexion Pharmaceuticals Inc. Appoints William R. Keller to its Board of Directors
12/2/2009
-
Alexion Pharmaceuticals Inc. to Present at Lazard Capital Markets 6th Annual Healthcare Conference
11/11/2009